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Abstract
Background: Newcastle disease (ND) is a devastating worldwide disease of poultry characterized by increased
respiration, circulatory disturbances, hemorrhagic enteritis, and nervous signs. Sequence analysis shows several
amino acid residue substitutions at neutralizing epitopes on the F and HN proteins of recent Shaanxi strains. Both
Cross protection and cross serum neutralization tests revealed that the traditional vaccine strains were unable to
provide full protection for the flocks.
Methods: To better understand the epidemiology of Newcastle disease outbreak, a portion of the F gene and
the full-length HN gene were amplified from Shaanxi isolates by reverse transcription-polymerase chain reaction
(RT-PCR) and then conducted sequence and phylogenetic analyzes. In pathogenicity analysis, both high intra-cerebral
pathogenicity index (ICPI) and mean death time (MDT) tests of chicken embryo were carried out. Furthermore, a
cross-protection experiment in which specific-pathogen-free chickens vaccinated with a LaSota vaccine strain were
challenged by the recent Shaanxi strain was also performed.
Results: Nine Newcastle disease (ND) virus (NDV) isolates which were recovered from ND outbreaks in chicken flocks in
China were genotypically and pathotypically characterized. Amino acid sequence analysis revealed that all the recent
Shaanxi-isolated NDVs have 112R-R-Q-K-R-F117 for the C-terminus of the F2 protein and exhibit high ICPI and MDT of
chicken embryos, suggesting that they were all classified as velogenic type of NDVs. Phylogenetic analysis of these
isolates showed that they belong to subgenotype VIId that have been implicated in the recent outbreaks in
northwestern China. The percentage of amino acid sequence identity of F protein between recent Shaanxi stains and
five vaccine strains was in the range of 81.9 %–88.1 %, while the percentage of amino acid sequence identity of HN
protein between recent Shaanxi strains and vaccine strains was in the range of 87.4 %–91.2 %. Furthermore, a number
of amino acid residue substitutions at neutralizing epitopes on the F and HN proteins of these isolates were observed,
which may lead to the change of antibody recognition and neutralization capacity. A cross-protection experiment
indicated that specific-pathogen-free chickens vaccinated with a LaSota vaccine strain was not capable of providing full
protection for the flocks that were challenged by the recent Shaanxi strain.
Conclusions: Taken together, our findings reveal that recent Shannxi NDVstrains exhibit antigenic variations that could
be responsible for recent outbreaks of NDVs in northwestern China.
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Background
Newcastle disease is a highly contagious disease, which
caused by the virulent strains of Newcastle disease virus
(NDV), and causes great economic loss to the global
poultry industry. In addition to poultry species, at least
250 species of birds can be naturally or experimentally
infected with NDV [1]. The major signs of the disease
include respiratory distress, diarrhea, circulatory distur-
bances, and central nervous system impairment [1–3].
Although NDV has only 1 serotype, ND outbreaks still
occur frequently in flocks vaccinated with NDV live vac-
cines (e.g. Lasota and Clone 30) and inactivated vaccines
in China. Immune failure is considered to be related to
the genetic variation of NDV epidemic strains [3–6].
On the basis of restriction fragment length poly-
morphism (RFLP) analysis and partial nucleotide se-
quencing of the cleavage recognition sequence of the F
gene, NDV strains are grouped into at least 10 gen-
ogroups, among which genogroup VII can be further di-
vided into several sub-genotypes [5, 7, 8]. The currently
circulating NDVs in the worldwide exhibit multiple ge-
notypes and high genetic diversity. According to patho-
genicity assays in specific pathogen free (SPF) chickens,
NDVs have been categorized into velogenic, mesogenic,
and lentogenic pathotypes. The F protein mediates the
fusion of viral and cellular membranes during penetra-
tion and spread between infected and adjacent cells. The
virulence of NDV can be predicted by analyzing the
cleavage site sequence of F protein [1, 9, 10]. By compar-
ing the amino acid residues of the C-terminal HN exten-
sion of NDV, they were divided into at least 3 groups,
including the numbers of amino acid residues of 571,
577 and 616 [11, 12]. The viral HN protein mediates at-
tachment to sialic acid-containing receptor(s) through
its neuraminidase (NA) activity. HN is a type II mem-
brane glycoprotein, which exists on the surface of virions
and infected cells as a tetrameric spike. The ectodomain
of the HN glycoprotein consists of a membrane-proximal,
stalk-like segment supporting a terminal globular domain.
The antigenic, receptor recognition, and NA active sites
all reside in the latter [13]. Previous studies have suggested
that there are at least five antigenic sites related to epi-
topes on the HN protein of NDV, which are related to
antibody recognition [13, 14].
In this study, nine NDV strains have been isolated
from NDV-infected chickens in Shaanxi province in
China. To investigate the epidemiology of Newcastle dis-
ease outbreak, a portion of the F gene and the full-
length HN gene were amplified from these isolates by
reverse transcription-polymerase chain reaction (RT-
PCR) and then conducted sequence analysis. The nu-
cleotide sequences of the F and HN genes of NDVs from
recent Shaanxi isolates were compared with published
sequences to clarify the evolution, epidemiology and
their pathotypes of NDV. Our findings reveal that all
Shaanxi NDV strains belong to genotype VIId. Sequence
analysis showed several amino acid residue substitutions
at neutralizing epitopes on the F and HN proteins of re-
cent isolated Shaanxi strains. Furthermore, cross protec-
tion and cross serum neutralization tests suggested that
the traditional vaccine strains such as LaSota were un-
able to provide full protection for the flocks.
Results
Pathogenicity analysis and RT-PCR
Nine NDV strains were isolated from NDV-infected
chickens during 2011 and named NDV/Chicken/TC/1/
2011, NDV/Chicken/TC/2/2011, NDV/Chicken/ TC/3
/2011, NDV/Chicken/TC/4/2011, NDV/Chicken/TC/5/
2011, NDV/Chicken/ TC/6 /2011, NDV/Chicken/TC/7/
2011, NDV/Chicken/TC/8/2011, and NDV/Chicken
/TC/9/2011 (Table 1). All Shaanxi strains of NDV with
MDT of 38–50 h and with ICPI of 1.67-1.78 (Table 1)
were classified as virulent NDVs. By using the primers F1
and F2, the fragments of the F gene were amplified from
all Shaanxi NDV isolates with the expected size of 957 bp
in length. By using the primer pairs (HN1-HN2 and HN3-
HN4), 2 PCR products (1002 and 1338 bp) covered the
full-length HN gene (1716 bp) could be amplified from all
Shaanxi NDV isolates (data not shown).
Nucleotide and amino acid sequence analysis of the F
gene of NDVs
All the recent Shaanxi strains contain the amino acid se-
quences 112R-R-Q-K-R-F117 for the C-terminus of the F2
protein, indicating that they are velogenic type of NDV.
Furthermore, all the recent Shaanxi strains possess 101 K
and 121 V (Table 2), a characteristic of genotype VII vi-
ruses reported previously [15].
The nucleotide and predicted amino acid sequences of
the F gene of NDVs were aligned. The aligned sequences
were then used in pairwise comparisons and the per-
centage of nucleotide and amino acid sequence identities
were determined.
The percentage of nucleotide sequence identity of F
gene among these Shaanxi strains was in the range of
98.9 %–99.6 %, while the percentage of amino acid
sequence identity was in the range of 98.4 %–99.5 %. Se-
quence comparisons of Shaanxi strains with five vaccine
strains (Herts/33, B1, Clone 30, LaSota, and Mukteswar)
homologues revealed that there exist extensive sequence
divergence, with 80.7 %–87.2 % and 81.9 %–88.1 % iden-
tities of nucleotide and amino acid sequence, respectively.
The Shaanxi strains exhibited higher sequence identity
with Herts/33 vaccine strain. The percentage of nucleotide
sequence identity was in the range of 86.6 %–87.2 %, while
the percentage of amino acid sequence identity was in the
range of 87.6 %–88.1 %. Furthermore, Shaanxi strains
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Table 1 Characterization of NDV strains used in this study
NDV strain COU HO Year PT Cleavage site112–117 GT ICPI F No. HN No.
Clone 30 USA CK 1999 V GRQGRL II NA Y18898 Y18898
B1 USA CK 2000 L GRQGRL II 0.13 AF309418 AF309418
LaSota USA CK 1950 L GRQGRL II 0.31 JF950510 JF950510
Mukteswar CH CK 2010 L RRQRRF III NA JF950509 JF950509
Herts/33 NL CK 2004 V RRQRRF IV 1.99 AY741404 AY741404
NL/152608/93 NL CK 1993 V RRQKRF VIIa NA JN986837 JN986837
chicken/Kudus/018/10 INA CK 2010 V RRQKRF VIIa NA HQ697260 HQ697260
chicken/Sweden/97 SE CK 1997 V RRQRRF VIIb NA GU585905 GU585905
Sterna/Astr/2755/2001 RUS CK 2001 V RRQRRF VIIb NA AY865652 AY865652
TW-99-175 TW CK 1999 V RRQKRF VIIc 1.73 EU604057 EU579448
XJ-2/97 CH CK 1997 V RRQKRF VIId 1.94 AF458011 AF458011
JS/1/97/Go CH GO 1997 V RRQRRF VIId 1.84 AF456435 AF456429
BP01 CH PE 1999 V RRQKRF VIId NA JN599167 JN599167
JS/5/06/Go CH GO 2006 V RRQKRF VIId NA EF211811 EF211811
HA-14-07-Ch CH CK 2007 V RRQKRF VIId NA GQ245787 GQ245787
JSD0812 CH DK 2008 V RRQKRF VIId NA GQ849007 GQ849007
sh09 CH CK 2009 V RRQKRF VIId NA GU124591 GU124592
chicken/China/JSX1/2010 CH CK 2010 V RRQKRF VIId NA JX519467 JX519467
JS-12-11-Ch CH CK 2011 V RRQKRF VIId NA JQ013866 JQ013842
Ch/SD672/12 CH CK 2012 V RRQKRF VIId NA KC020114 JX914489
NDV/Chicken/TC/1/2011 CH CK 2011 V RRQKRF VIId 1.78 KC020314 KC020305
NDV/Chicken/TC/2/2011 CH CK 2011 V RRQKRF VIId 1.76 KC020315 KC020306
NDV/Chicken/TC/3/2011 CH CK 2011 V RRQKRF VIId 1.73 KC020316 KC020307
NDV/Chicken/TC/4/2011 CH CK 2011 V RRQKRF VIId 1.75 KC020317 KC020308
NDV/Chicken/TC/5/2011 CH CK 2011 V RRQKRF VIId 1.67 KC020318 KC020309
NDV/Chicken/TC/6/2011 CH CK 2011 V RRQKRF VIId 1.68 KC020319 KC020310
NDV/Chicken/TC/7/2011 CH CK 2011 V RRQKRF VIId 1.67 KC020320 KC020311
NDV/Chicken/TC/8/2011 CH CK 2011 V RRQKRF VIId 1.70 KC020321 KC020312
NDV/Chicken/TC/9/2011 CH CK 2011 V RRQKRF VIId 1.69 KC020322 KC020313
PX2/03 CH DK 2003 V RRQKRF VIId NA EF175145 EF175145
Hebei/01/2012 CH CK 2012 V RRQKRF VIId 1.73 KC542914 KC542914
Shandong/02/2012 CH CK 2012 V RRQKRF VIId NA KC542913 KC542913
YZCQ/Liaoning/08 CH CK 2008 V RRQKRF VIId NA FJ608351 FJ608369
Beijing/01/2012 CH CK 2012 V RRQKRF VIId 1.91 KC542911 KC542911
SD-02-11-Ch CH CK 2011 V RRQKRF VIId NA JQ013878 JQ013849
Ch/SD754/12 CH CK 2012 V RRQKRF VIId NA JX840452 JX840450
Ch/SD755/12 CH CK 2012 V RRQKRF VIId NA JX840453 JX840451
Ch/SD758/12 CH CK 2012 V RRQKRF VIId NA JX840455 JX683723
Ch/SD01/13 CH CK 2013 V RRQKRF VIId NA KF055273 KF055274
TW/99-156B TW CK 1999 V RRQKRF VIIe 1.79 AF234031 AF400504
TW-02-301 TW CK 2002 V RRQKRF VIIe 1.75 DQ898538 EU526302
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showed the lowest sequence identity with B1 vaccine
strain, with 80.7 %–81.3 % and 81.9 %–82.4 % identity of
nucleotide and amino acid sequence, respectively. Add-
itionally, the percentage of nucleotide sequence identity of
the F gene of NDV between Shaanxi and LaSota vaccine
strains was in the range of 81.7 %–82.3 %, while the per-
centage of amino acid sequence identity of NDV F protein
was in the range of 82.8 %–83.3 %.
Comparison of the deduced amino acid sequences of
the F protein of recent Shaanxi strains with the trad-
itional vaccine strains revealed that there were many
amino acid residue substitutions at F protein (Table 2).
Interestingly, compared to the past pandemic strains in
China during the past 10 years [16–20], a number of
amino acid residue substitutions at N-terminal of F pro-
tein were found in Shaanxi NDV strains. Examples in-
clude amino acid residue substitutions of all NDV at
positions 13 (M to L and M to P), 14 (M to V), 19 (I to
V or T to V), 22 (V to A, V to T and V to I), 28 (P to L,
P to T and P to S), and 51 (N to S) (Table 2). It is worth
to note that two of amino acid residues at positions
14(V) and 51(S) were identified as specific for recent
Shaanxi NDV strains in compared to the past pandemic
strains in China (Table 2). Taken together, our results of
the present work provide evidences suggesting that ex-
tensive sequence divergence occur among Shaanxi
strains, past pandemic strains in China, and vaccine
strains.
Sequence analysis of NDV isolates of HN gene of NDV
Based on the C-terminal HN extension of NDV, 4
groups were classified, including amino acid residues of
571, 577, 580, and 616 [14]. In the current study, we
found that recent Shaanxi strains have HN gene encod-
ing only 571 amino acid residues of HN glycoprotein.
The percentage of nucleotide sequence identity of HN
gene among recent Shaanxi strains was in the range of
99.0 %–99.7 %, while the percentage of amino acid se-
quence identity was in the range of 98.5 %–99.6 %. Fur-
thermore, the percentage of nucleotide sequence identity
of HN gene between Shaanxi and vaccine strains was in
the range of 81.4 %–84.8 %, while the percentage of
amino acid sequence identity was in the range of
87.5 %–91.2 %. Sequence analysis of Shaanxi and vaccine
strains exhibited that recent Shaanxi strains of NDV had
the lowest percentage of sequence identity with LaSota
vaccine strain. The percentage of nucleotide and amino
acid sequence identity between recent Shaanxi and LaSota
vaccine strains was in the range of 81.4 %–81.6 % and
87.5 %–88.0 %, respectively.
Amino acid residue substitutions at neutralizing epitopes
on the HN glycoprotein among Shannxi isolates of NDV
Analysis of antigenic sites on the HN glycoprotein of re-
cent Shaanxi NDV strains revealed that there are many
amino acid residue substitutions at neutralizing epitopes
on HN protein (Table 3). As compared to vaccine strains
(Herts/33, B1, Clone 30, LaSota, and Mukteswar), many
amino acid residue substitutions at positions 347E→ R
(sites 1 and 14), 350Y→H (sites 1 and 14), 494G→D
(site 1 2), 514I→V (sites 2 and 12), 518S→N (sites 2
and 12), 519S→ L (sites 2 and 12) were found in recent
Shaanxi strains of NDV (Table 3). Furthermore, in com-
parison to the past pandemic strains in China during the
past 10 years, several amino acid residue substitutions at
neutralizing epitopes on HN protein were uncovered in
recent Shaanxi strains. Examples include amino acid
residue substitutions at positions 347 (E to R) with
JSD0812 whose host was duck and 347 (E to R) with
sh09 whose host were chickens as well as 518S→N
(sites 2 and 12) and 519S→ L (sites 2 and 12) (Table 3).
Additionally, compared to the recent Taiwanese NDV
isolates, several amino acid residue substitutions at neu-
tralizing epitopes on the HN protein at positions
347G→ R, 348H→Q, 350Y→H, 352 T→ I, 518S→N
and 519S→ L were also uncovered (Table 3). It is inter-
esting to note that 4 amino acid residues at positions
347(R), 350(H), 518 (N), and 519 (L) were conserved in
recent Shaanxi NDV isolates and identified as a specific
marker for these isolates (Table 3).
Previous reports showed that LaSota vaccine can be
fully protected against challenge by strains from genetic
groups VIb, VIg, VIId and IX [16, 21]. As compared to
APMV-1/ chicken/NL/152608/93 [21], we found several
substitutions in F and HN proteins of shaanxi NDV iso-
lates, such as in the amino acid sequences of F gene with
9I→T, 13P→ L, 14 V→M, 16 V→ I, 19 V→ I,
22 T→ I, 23 L→ S, 27R→C, 28P→ L, 29 T→V,
Table 1 Characterization of NDV strains used in this study (Continued)
TW-02-302 TW CK 2002 V RRQKRF VIIe 1.75 DQ898537 EU526303
TW-04-CB8 TW CK 2004 V RRQKRF VIIe 1.75 DQ898528 AB531987
TW/08-02 TW CK 2008 V RRQKRF VIIe NA AB512614 AB531988
NL/152608/93: APMV-1/chicken/NL/152608/93; Hebei/01/2012: chicken/China/ Hebei/01/2012; Shandong/02/2012: chicken/China/ Shandong/02/2012; Beijing/01/2012:
chicken/China/ Beijing/01/2012. CH: China; NL: Netherlands; INA: Indonesia; SE: Sweden; RUS: Russia; TW: Taiwan; GO: Goose; CK: Chicken; DK: Duck; PE: Penguin; COU:
Country; HO: Host; PT: Pathotype; GT: Genotype; F no.: F gene accession no.; HN no.: HN gene accession no.; NA: not available
Clone 30, LaSota, Mukteswar and B1 strains are attenuated vaccine strains that widely used in the China and world; the Herts/33 are inactivated vaccine strains
that used Taiwan
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Table 2 Alignment of deduced amino acid sequences of the F protein of NDV
strains Amino acid residues
Clone 30 M G S R P S T K N P A P M M L T I R V A L V L S C I C P A N S I D G R P L A A A 40
B1 . . . . . F . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . F . . .
LaSota . . . . . . . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . . . . .
Mukteswar . . P . S . . R I . V . L . . . . . I T . A . . V R Q T V S . L . . . . . . . .
Herts/33 . . . . S . . R I . V . P . . I . . I V . T . . . . Q T V S . L . . . . . . . .
NL/152608/93 . . . K . . . R T . V . L . . I T . I M . I S . . . . L V S . L . . . . . . . .
chicken/Kudus/018/10 . . . K . . . R I . V . L . . I T . I M . I . . Y . . L V S . L . . . . . . . .
chicken/Sweden/97 . . . K . . . R I . V . L . . I T . . M . I . . . . R S I S . L . . . . . . . .
Sterna/Astr/2755/2001 . . . K . . . R I L V . L . . I T . . M . I . . . V R S T S . L . . . . . . . .
TW-99-175 . . . . S F . R I . . . L . . I T . I M . I . . . . . L T S . L . . . . . . . .
XJ-2/97 K R I L I T I M I R L T S L
JS/1/97/Go . . P K S . . N V . . . L . . . V . I . . A . . . V R L T . . L . . . . . . . .
BP01 . . . K . . . R I . . . L . . I T . I M . I . G . . R . T S . L . . . . . . . .
Guangxi9/2003 . . . K . . . R S . . . L . . I . . I M . I . . . . R . T S . L . . . . . . . .
JS/9/05/Go . . P . S . . R I . V . L . . T . . I T . A . . V R Q T V S . L . . . . . . . .
HA-14-07-Ch . . . K . . . R I . . . L . . V T . I M . I . G . . R . T S . L . . . . . . . .
JSD0812 . . . K . . . R I . . . L . . I T . T M . I . G . . . . T S . L . . . . . . . .
sh09 . . . . . . . R I . . . L . . I T Q I M . I . . . . . . T S . L . . . . . . . .
chicken/China/JSX1/2010 . . . K S . . R I . . . P . . V T . I M . I . G . . R . T S . L . . . . . . . .
JS-12-11-Ch . . . K L . . R I . . . L . . I T . I I . I . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/1/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/2/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/3/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/4/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/5/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/6/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/7/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/8/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
NDV/Chicken/TC/9/2011 . . . K . . . R I . . . P V . V T . . M . T . . . . R . T S . L . . . . . . . .
PX2/03 . . . K . . . R V . . . L . . I T . I M . I . G . . . S T S . L . . . . . . . .
Chicken/China/
Hebei/02/2012










Table 2 Alignment of deduced amino acid sequences of the F protein of NDV (Continued)
Shangdong/02/2012 . . . K . . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
YZCQ/Liaoning/08 . . . K . . . R I . . . L . . I T . I M . I . D . . R . T S . L . . . . . . . .
Beijing/01/2012 . . . K . . . . I . V . L . . I T . I M . I . N . . R L T S . L . . . . . . . .
SD-02-11-Ch . . . K L . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
Ch/SD672/12 . . . K . . . R I . . . L . . I T . I M . T . . . . R . T S . L . . . . . . . .
Ch/SD754/12 . . . K . . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
Ch/SD755/12 . . . K . . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
Ch/SD758/12 . . . K . . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
Ch/SD01/13 . . . K . . . R I . . . L . . I T . I L . I . N . . R L T S . L . . . . . . . .
TW/99-156B . . . . S . . R I . . . L . . . T Q I M . T . . . . R L T S . L . . . . . . . .
TW-02-301 . . P . S . . R I . . . L . . I T . I M . T F . . . R L T S . L . . . . . . . .
TW-02-302 . . . . S . . R I . . . L . . I T . I M . T F . . . R L T S . L . . . . . . . .
TW-04-CB8 . . P . S . . R I . . . L . . I T . I M . T . . . . R L T S . L . . . . . . . .
TW/08-02 . . P Q T F . R I . . . L . . I T . I M . T F . . T R L . S . L . . . . . . . .
strains Amino acid residues
Clone 30 G I V V T G D K A V N I Y T S S Q T G S I I V K L L P N L P K D K E A C A K A P 80
B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LaSota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mukteswar . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
Herts/33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
NL/152608/93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
chicken/Kudus/018/10 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . . . . . . . . . . .
chicken/Sweden/97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
Sterna/Astr/2755/2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
TW-99-175 . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
XJ-2/97 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
JS/1/97/Go . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . .
BP01 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
JS/5/06/Go . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
HA-14-07-Ch . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
JSD0812 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .










Table 2 Alignment of deduced amino acid sequences of the F protein of NDV (Continued)
chicken/China/JSX1/2010 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
JS-12-11-Ch . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/1/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/2/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/3/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/4/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/5/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/6/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/7/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/8/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
NDV/Chicken/TC/9/2011 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
PX2/03 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . . .
Chicken/China/
Hebei/02/2012
. . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . . .
Shangdong/02/2012 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
YZCQ/Liaoning/08 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . . . . . . . . . D . .
Beijing/01/2012 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
SD-02-11-Ch . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
Ch/SD672/12 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . . . .
Ch/SD754/12 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
Ch/SD755/12 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
Ch/SD758/12 . . . . . . . . . . . V . . . . . . . . . . . . . . . . M . R . . . . . . R . . .
Ch/SD01/13 . . . . . . . . . . . V . . L . . . . . . . . . . . . . M . R . . . . . . R . . .
TW/99-156B . . . . . . . . . . . V . . . . . . . . . . . . . . . . I . . . . . . . . . . .
TW-02-301 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . . . . . . . . . . .
TW-02-302 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . . . . . . . . . . .
TW-04-CB8 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . . . . G . . . . . .
TW/08-02 . . . . . . . . . . S V . . . . . . . . . . . . . . . . M . . . . . G . . . . .
strains Amino acid residues
101 112 117 121
Clone 30 L D A Y N R T L T T L L T P L G D S I R R I Q E S V T T S G G G R Q G R L I G A I I G 123
B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .










Table 2 Alignment of deduced amino acid sequences of the F protein of NDV (Continued)
Mukteswar . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . R . F . . . . . .
Herts/33 . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . R . F . . . . . .
NL/152608/93 . E . . . . . . . . . . . . . . . . . . K . . G . . S . P . . R . . K . F . . . V . .
chicken/Kudus/018/10 . E . . . . . . . . . . . . . . . . . . K . . G . . A . . . . R . . K . F . . . V . .
chicken/Sweden/97 . E . . . . . . . . . . . . . . . . . . . . . G . . S . . . . R . . R . F . . . V . .
Sterna/Astr/2755/2001 . E . . . . . . . . . . . . . . . . . . . . . G . . S . . . . R . . R . F . . . V . .
TW-99-175 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
XJ-2/97 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
JS/1/97/Go . E . . . . . . . . . . . . . . . . . . . . . . . A . . . . . R . . R . F . . . . . .
BP01 . E . . . . . . . A . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
JS/5/06/Go . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
HA-14-07-Ch . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
JSD0812 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
sh09 . E . . . . . . . . . . . . . . . . . . K . . G . . Y . . . . R . . K . F . . . V . .
chicken/China/JSX1/2010 . E . . . . . . . A . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
JS-12-11-Ch . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/1/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/2/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/3/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/4/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/5/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/6/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/7/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
KNDV/Chicken/TC/8/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
NDV/Chicken/TC/9/2011 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
PX2/03 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . G . R . . K . F . . . V . .
Hebei/02/2012 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
Shangdong/02/2012 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
YZCQ/Liaoning/08 . E . . . . . . . . . . . . . . E . . . K . . G . . S . . . . R . . K . F . . . V . .
Beijing/01/2012 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
SD-02-11-Ch . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .










Table 2 Alignment of deduced amino acid sequences of the F protein of NDV (Continued)
Ch/SD754/12 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . V . .
Ch/SD755/12 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
Ch/SD758/12 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
Ch/SD01/13 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
TW/99-156B . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
TW-02-301 . E . . . . . . . A . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
TW-02-302 . E . . . . . . . A . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
TW-04-CB8 . E . . . . . . . . . . . . . . . . . . K . . G . . S . . . . R . K K . F . . . V . .
TW/08-02 . E . . . . . . . A . . . . . . . . . . K . . G . . S . . . . R . . K . F . . . V . .
Only sequences different from the NDV strain Clone 30 are shown. The sequences at the fusion cleavage site and residues discussed in the text are underlined
Residues that are identical to the NDV strain Clone 30 are indicated by a dot (.). The other published sequences were indicated in Table 1 and described previously [2, 5]. NL/152608/93: APMV-1/chicken/NL/152608/93;










Table 3 Alignment of HN amino acid sequences of recent Taiwanese isolates and previously published virus strains was performed
using the DNASTAR software
Amino acid residues
Strains HR-A 74-89 HR-B 96-110
Clone 30 L G S N Q D V V D R I Y K Q V A L L N T E T T I M N A I S L
B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LaSota . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . .
Mukteswar . . . . . . . . . . . . . . . . . . . . . S I . . . . . . . .
Herts/33 . S . . . . . . . . . . . . . . . . . . . S V . . . . . . . .
NL/152608/93 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
chicken/Kudus/018/10 . S . S . . . I . . . . . . . . . . . . . S M . . . . . . . .
chicken/Sweden/97 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
Sterna/Astr/2755/2001 . . . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
TW-99-175 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
XJ-2/97 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
JS/1/97/Go . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
BP01 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
JS/5/06/Go . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
HA-14-07-Ch . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
JSD0812 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
sh09 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
chicken/China/JSX1/2010 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
JS-12-11-Ch . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
NDV/Chicken/TC/1/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/2/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/3/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/4/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/5/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/6/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/7/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/8/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
NDV/Chicken/TC/9/2011 . S . S . . . I . . . . . . . . . . . . . S . . . . . . . . .
PX2/03 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
Chicken/China/Hebei/02/2012 . S . S . . . I . . . . . . . . . . . . . S I . . . . . . . .
Shangdong/02/2012 . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
YZCQ/Liaoning/08 . S . S . . . I . . . . . . . . . . . . . S M . . . . . . . .
Beijing/01/2012 . S . S . . . I . . . . . . . . . . . . . S V . . . . . . . .
SD-02-11-Ch . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
Ch/SD672/12 . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
Ch/SD754/12 . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
Ch/SD755/12 . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
Ch/SD758/12 . S . S . . . I . . . . . . . . . . . . . S V . . . . . . . .
Ch/SD01/13 . S . G . . . I . . . . . . . . . . . . . S V . . . . . . . .
TW/99-156B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
TW-02-301 . S . S . . . M . . . . . . . . . . . . . S I . . . . . . . .
TW-02-302 . S . S . . . M . . . . . . . . . . . . . S I . . . . . . . .
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Table 3 Alignment of HN amino acid sequences of recent Taiwanese isolates and previously published virus strains was performed
using the DNASTAR software (Continued)
TW-04-CB8 . S . S . . . M . . . . . . . . . . . . . S I . . . . . . . .
TW/08-02 . S . S . . . M . . . . . . . . . . . . . S I . . . . . . . .
Amino acid residues
Strains Site 23 Site 1 and 14 Site 12 Site 2 and 12 Site 2
Clone 30 193-201 345-355 494 513-521 569
L S G C R D H S H P D E Q D Y Q I R M A G R I T R V S S S D
B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LaSota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mukteswar . . . . . . . . . . . . . . . . . . . . D . . . . . . . . . G
Herts/33 . . . . . . . . . . . . . . . . . . . . D . . . . . . . R . .
NL/152608/93 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
chicken/Kudus/018/10 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . N
chicken/Sweden/97 . . . . . . . . . . . . . . . . . . . . D . V . Q . . . . . A
Sterna/Astr/2755/2001 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . V
TW-99-175 . . . . . . . . . . . G . . . . . . . . D . V . . . . . . . .
XJ-2/97 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
JS/1/97/Go . . . . . . . . . . . G . . . . . . . . D . V . . . . . . . .
BP01 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
JS/5/06/Go . . . . . . . . . . . G . . . . . . . . D . V . . . . . . . .
HA-14-07-Ch . . D . . . . . . . . G . . . . . . . . D . V . . . . . . . .
JSD0812 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
sh09 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
chicken/China/JSX1/2010 . . . . . . . . . . . G . . H . . . . . D . V . . . . . . . .
JS-12-11-Ch . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
NDV/Chicken/TC/1/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/2/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/3/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/4/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/5/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/6/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/7/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/8/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
NDV/Chicken/TC/9/2011 . . . . . . . . . . . R . . H . . . . . D . V . . . N L . . .
PX2/03 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
Chicken/China/Hebei/02/2012 . . . . . . . . . . . . . . . . . . . . D . V . . . . . . . .
Shangdong/02/2012 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
YZCQ/Liaoning/08 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
Beijing/01/2012 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
SD-02-11-Ch . . . . G . . . . . . K . . . . . . . . D . V . . . . . . . .
Ch/SD672/12 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
Ch/SD754/12 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
Ch/SD755/12 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
Ch/SD758/12 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
Ch/SD01/13 . . . . . . . . . . . K . . . . . . . . D . V . . . . . . . .
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51S→N, 109S→ P, and in the HN gene with 102 T→ I,
350H→ Y, 518 N→ S, and 519 L→ S. As compared to
XJ-2/97 NDV genotype VIId strains [16], several substi-
tutions in F and HN proteins of shaanxi NDV isolates
were found, such as in the amino acid sequences of F
gene with 14 V→M, 16 V→ I, 19 V→ I, 22 T→ I,
28P→ L, 51S→N, and in the HN gene with 102 T→ I,
350H→ Y, 518 N→ S, and 519 L→ S. As compared to
JS/1/97/Go NDV genotype VIId strains [16], several sub-
stitutions in F and HN proteins of shaanxi NDV isolates
were found, such as in the amino acid sequences of F
gene with 3S→ P, 5P→ S, 8R→N, 9I→V, 13P→ L,
14 V→M, 16 V→T, 17 T→V, 19 V→ I, 20 M→A,
22 T→A, 26I→V, 28P→ L, 51S→N, 52 V→ I,
71R→K, and 121 V→ I as well as in the HN gene with
102 T→ I, 347R→G, 350H→ Y, 518 N→ S, and
519 L→ S. These amino acid residue substitutions may
change antigenicity of recent shaanxi NDV strains. More
recently, it was reported that a substitution at amino
acid residue 81 (I to M or V to M) in the hepta repeated
regions of HA glycoprotein reduces HA activity [14].
However, similar mutation was not found in the Shaanxi
strain. Additionally, examination of the critical amino
acid residues 401E, 416R, and 526Y for receptor binding
[22] in the HN glycoprotein of recent Shaanxi strains of
NDV were also conserved.
Phylogenetic analysis of F and HN genes of NDV
Based on the nucleotide sequences (1–389 bp) of the F
gene among NDV isolates, a phylogenetic tree was con-
structed (Fig. 1). The reference strains cover traditional
vaccine strains and different pandemic VII genotype NDV
strains in China (Fig. 1; Table 1). All recent Shaanxi strains
were phylogenetically closely related and belonged to gen-
etype VIId (Fig. 1). Furthermore, all recent Shaanxi strains
were not phylogenetically related to vaccine strains, such
as Mukteswar, Clone 30, Lasota, B1 and Herts/33. Fur-
thermore, all recent Shaanxi strains were
phylogenetically related to HA-14-07-Ch and JS/5/06/
Go NDV strains that were isolated from the Eastern
China.
Based on nucleotide sequences of the full-length HN
gene among NDV isolates, a phylogenetic tree was cre-
ated (Fig. 2). The results in Fig. 2 showed that all recent
Shaanxi strains were phylogenetically closely related and
had only 571 amino acid residues. Besides, all these
strains were phylogenetically related to chicken/China/
JSX1/2010, HA-14-07-Ch and JS/5/06/Go isolated from
the Eastern China. However, all recent Shaanxi strains
were not phylogenetically related to vaccine strains. In
addition, JS/1/97/Go strain was closely related to the
vaccine strain Mukteswar and Herts/33 in the phylogen-
etic tree based on a variable portion (nt 1–389) of the F
gene, but JS/1/97/Go strain was closely related to HA-
14-07-Ch in the phylogenetic tree creased on the basis
of the full-length HN gene.
Relatedness (R) values of Shaanxi and LaSota strains
The neutralizing antibody (NA) titers of LaSota and
NDV/Chicken/TC/1/2011 vaccination hyperimmune sera
were determined by neutralization test. While NDV
LaSota was used as an antigen, the NA geometric mean
titer (GMT) to both LaSota and NDV/Chicken/TC/1/
2011 sera were 128 and 148, respectively. Furthermore,
the NA GMT to both LaSota and NDV/Chicken/TC/1/
2011 vaccination sera were 67.2 and 241.8, respectively
when all nine recent Shannxi strains were used as
antigens.
Relatedness (R) values, determined by cross VN, re-
vealed that all the recent Shaanxi isolates are closely re-
lated and belonged to a single serotype. However, the
cross VN test revealed that R values obtained between
NDV/Chicken/TC/1/2011 and LaSota vaccine strain was
0.54, indicating that they were minor subtype difference.
Hemagglutination inhibition assay
The HI assay was employed to evaluate antibody titers
using LaSota antigens. As illustrated in Table 4, the HI
titer was undetectable in un-inoculated and negative
control group chickens. The chickens exhibited HI titer
that received Oil-TC/1 were 7.1 log2, received Oil-Las
were 7.2 log2, received Live-Las were 7.0 log2, received
Table 3 Alignment of HN amino acid sequences of recent Taiwanese isolates and previously published virus strains was performed
using the DNASTAR software (Continued)
TW/99-156B - - - - - - - - - . . G H . . . . . - - - - - - - - - - - - - -
TW-02-301 . . . . K . . L . . . G . . . . T . . . D . V . . . . . . . .
TW-02-302 . . . . K . . . . . . G . . . . T . . . D . V . . . . . . . .
TW-04-CB8 . . . . K . . . . . . G . . . . T . . . D . V . . . . . . . .
TW/08-02 . . . . . . . . . . . G . . . . T . . . D . V . . . . . . . .
Residues that are identical to the NDV Clone 30 strain are indicated by a dot (.). The hepta repeated HR-A and HR-B (amino acid residues 74 to 110) and C-terminal
extension are indicated above the amino acid sequences. Five antigenic sites on HN protein of NDV, including residues 193–201 (site 23), 345–355 (sites 1 and 14) and a
C-terminal domain composed of residues 494 (sites 12), 513-521(sites 12 and 2), and 569 (sites 2) are shown [5]. NL/152608/93: APMV-1/ chicken/NL/ 152608/93; Hebei/
01/2012: chicken/China/ Hebei/01/2012; Shandong/ 02/2012: chicken/China/Shandong/02/2012; Beijing/01/2012: chicken/China/ Beijing/01/2012
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Oil-TC/1and Live-Las were 8.1 log2, received Oil-Las
and Live-Las were 8.7 log2.
The cross-HI assay was employed to evaluate the HI
antibody titers using different antigens between NDV/
Chicken/TC/1/2011 and LaSota. Anti-NDV/Chicken/
TC/1/2011 hyperimmune serum was used as an anti-
body, the HI titer were 9Log2 when using the homolo-
gous antigens and7Log2 when using the vaccine strain
LaSota. When anti-NDV LaSota hyperimmune serum
was used as an antibody, the HI titer were 10Log2 that
using the homologous antigens and 7Log2 that using
NDV/Chicken/TC/1/2011.
Neutralization test and cross-protectivity experiments
As shown in Table 5, neutralization titers of chicken im-
munized with different vaccine combinations while
NDV/Chicken/TC/1/2011 strain was used as an antigen
in neutralization test. The neutralization titer was un-
detectable in both un-inoculated and negative control
group chickens. Our results reveal that chickens having
neutralization titers of 64 could be protected against
challenge with the NDV/Chicken/TC/1/2011 strain
(Table 5).
To evaluate the protective efficacy of different vaccine
combinations, the cross protectivity of each group vac-
cine was assessed in 3 week after the last vaccine
(Table 6). Chickens in the negative control groups had
no clinical signs during the course of the experiments.
All birds in the un-inoculated control group displayed
severe depression and typical lesions from day 3 to 5 pc
and 100 % mortality was observed on day 7 pc. Necropsy
of these un-inoculated control birds revealed gross le-
sions consistent with a virulent NDV infection including
hemorrhages and edema in the conjunctiva of the lower
eyelid, petechial hemorrhages in the thymus, and multi-
focal hemorrhage of the proventriculus. No obvious clin-
ical signs or mortality was observed in birds receiving
either Oil-TC/1 or Oil-TC/1and Live-Las vaccines, and
conferred protection from morbidity and death in all
chickens subjected to the NDV/Chicken/TC/1/2011
strain challenge (Table 6).
Obvious clinical signs were seen in part of other 3 vac-
cinated groups by 3 days post-inoculation (dpi). They
displayed depressed, consumed less food and water. Two
birds died on 5 dpi in Oil-Las group during the experi-
ment, and the mortality rate was 17 %. Three birds died
on 5 and 7 dpi in LaSota attenuated vaccines group dur-
ing the experiment, and the mortality rate was 25 %
(Table 6). One birds died on 7 dpi in the Oil-Las and
Live-Las vaccines group during the experiment, the mor-
tality rate was 9 %. However, both Oil-Las and LaSota
attenuated vaccines conferred protection 83 % and 75 %
of chickens, respectively. Furthermore, combination of
the Oil-Las and Live-Las vaccine conferred protection to
92 % of chickens challenged with the NDV/Chicken/TC/
1/2011 strain (Table 6).
Frequency of isolation of challenge virus in different
vaccine groups
Virus shedding was examined in all experimental chick-
ens on day 0, 2, 4, 6, and 9 pc. As shown in Table 7, vi-
ruses could be detected in both oropharyngeal and
cloacal swabs in challenge un-inoculated control group
from day 2 pc. No virus was isolated from any bird in
the negative control group. On day 4 pc, there were
83.3 %, 75 % and 66.7 % positive oropharyngeal swabs
could be detected respectively from the Oil-Las vaccines
group, Live-Las vaccines group and the vaccines group
with Oil-Las and Live-Las. In this study, chickens immu-
nized with an Oil-TC/1 vaccine have lower viruses shed-
ding in day 2 pc from oropharyngeal samples than those
immunized with a Live-Las vaccine (Fig. 3a). The virus
titers of oropharyngeal swabs from both Oil-TC/1- and
Oil-TC/1 plus Live-Las-inoculated chickens were signifi-
cantly reduced compared to the titers of three other vac-
cinated groups as well as the un-inoculated control
(Fig. 3b).
Discussion
There have been at least four major outbreaks of New-
castle disease worldwide so far and every epidemic had
its specific genotypes [4, 23]. The NDVs currently circu-
lating worldwide exhibit multiple genotypes. Outbreaks
of Newcastle disease in vaccinated chicken flocks have
been reported previously in China and even in Taiwan
[2, 3, 5, 24]. Velogenic NDV strains were isolated from
egg layer flocks with NDV vaccine immunization failure
in China [24, 25]. To date, the genotype VII of NDVs is
predominant in the domestic poultry of Asia. The sub-
genotypes VIIc and VIId of NDVs existed in China and
Far East countries [20, 24, 26], while sub-genotype VIIe
of NDVs was found in Taiwan [5]. Earlier studies have
suggested that high genetic diversity and multiple geno-
types of NDVs in China were found [17, 19, 24, 27].
Sub-genotypes VIIc andVIId of NDVs were the major
(See figure on previous page.)
Fig. 1 Phylogenetic tree of the nucleotide sequence of NDV strains based on a variable portion (nt 1–389) of the F gene. The accession numbers of
the sequences derived in this study and those derived from GenBank were shown in Table 1. The tree was constructed using MEGA 4 neighbor-
joining method with 1000 replicates of bootstrap. Genotype, sub-genotype and recently Chinese isolates are indicated on the right.▲: Shaanxi
NDV isolates
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epidemic strains in China in recent years and could
evolve into other NDV genotypes [24].
Analysis of the deduced amino acid sequences of the F
protein of recent Shaanxi strains revealed that all these
isolates possessed the amino acid sequences 112R-R-Q-
K-R-F117 for the C-terminus of the F2 protein, indicating
that they were all highly pathogenic viruses. The result
was consistent with the pathogenicity assay. Addition-
ally, all the recent Shaanxi strains had 101 K and 121 V,
a characteristic of genotype VII viruses [15]. Further-
more, phylogenetic analysis indicated that all Shaanxi
strains were classified as sub-genotype VIId. Analysis of
deduced amino acid sequences of the F protein of recent
Shannxi and traditional vaccine strains revealed many
amino acid residue substitutions. It is worth to note that
many amino acid residue substitutions on F protein of
recent Shannxi NDV strains were also found as com-
pared to the pandemic strains in China during the past
10 years. The findings suggest that these mutations on
the F proteins may change antigenicity of recent Shaanxi
NDV strains.
Earlier studies have demonstrated that the viral HN
protein mediates attachment to sialic acid-containing re-
ceptor(s) via its neuraminidase (NA) activity, the appar-
ently opposing activity of release of sialic acid from
soluble and membrane-associated glycoconjugates [28–
31]. It was also suggested that there are at least 5 anti-
genic sites related to neutralizing epitopes on the HN
protein of NDV, such as residues 193 to 201 (site 23),
residues 345 to 355 (sites 1 and 14) and a C-terminal do-
main composed of residues 494, 513 to 521, and 569
(sites 12 and 2). Furthermore, monoclonal antibodies
(MAbs) to 3 overlapping sites (2, 12, and 23) on HN
glycoprotein suppressed the NA activity of the virus [32,
33]. MAbs to sites (1 and 14) inhibited HA predomin-
antly by preventing viral attachment to chick cells [32,
34]. As compared to vaccine and the past pandemic
strains in China, recent Shaanxi NDV strains reveal a
number of amino acid residue substitutions at neutraliz-
ing epitopes on HN protein, which suggest that these
mutations may lead to antigenic change and have effect
on viral attachment to the receptor on the cell surface
[33, 35]. This divergence further elucidates that amino
acid residue substitutions may lead to the change of
antibody recognition capabilities and types. Apparently,
some new immune response-escaping antigenic variants
were developed and resulted in ND outbreaks in
Shannxi province in China. In this work, an inactivated
oil mulsion (Oil-TC/1) vaccine prepared from a recent
Shannxi isolate (NDV/Chicken/TC/1/2011), conferred
protection from morbidity and death in all chicks sub-
jected to homologous challenge whereas the inactivated
oil mulsion Lasota vaccine (Oil-Las) and LaSota attenu-
ated vaccine (Live-Las) conferred clinical protection to
only 83 % and 75 % of chicks, respectively challenged
with NDV/Chicken/TC/1/2011. It can be speculated that
immunization failure may be caused by the difference of
antigenic sites between vaccine strains and field strains.
In an earlier study, Liu and his colleagues also showed
that SPF chickens vaccinated with LaSota vaccines could
be fully protected against challenge by strains from gen-
etic groups VIb, VIg, VIId, and IX [16]. Recently, Cornax
et al. reported LaSota vaccine could provide full protec-
tion for NDV genotype VIId [21]. Conversely, several re-
ports in using LaSota vaccine to immunize chicken in
China or Taiwan [5, 25] demonstrated that LaSota vac-
cine could not provide full protection for genotype VII
of NDV. In the present study, LaSota vaccine was not
Table 4 The titer of HI antibody of all birds immunized with different vaccines using the LaSota antigen
Number of chicken Mean value
Group 1 2 3 4 5 6 7 8 9 10 11 12
Oil- TC/1 6a 8 7 6 8 8 8 8 7 6 6 7 7.1
Oil-Las 7 7 6 9 8 7 7 7 6 7 9 6 7.2
Live-Las 7 7 7 8 7 8 6 7 6 6 7 8 7.0
Oil-TC/1 plus Live-Las 8 8 8 9 8 10 8 7 8 6 8 9 8.1
Oil-Las plus Live-Las 8 8 9 10 8 10 8 9 8 8 9 8 8.7
Un-inoculated control 0 0 0 0 0 0 0 0 0 0 0 0 0
Negative control 0 0 0 0 0 0 - - - - - - 0
aThe titer of HI antibody was expressed on a log 2 scale. All chickens (n = 6) in the negative control group had no clinical signs during the course of
the experiment
(See figure on previous page.)
Fig. 2 Phylogenetic tree creased on the basis of the full-length HN gene of NDV isolates and reference strains. The accession numbers of the
sequences derived in this study and those derived from GenBank were shown in Table 1. The tree was constructed using MEGA 4 neighbor-
joining method with 1000 replicates of bootstrap. Genotype, sub-genotype and recently Chinese isolates are indicated on the right. ▲: Shaanxi
NDV isolates
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capable of providing full protection for the flocks. As
compared to APMV-1/chicken/NL/152608/93, XJ-2/97,
and JS/1/97/Go NDV strains of genotypes VIId and VIIb
[16, 21], we found several substitutions in both F and
HN proteins of shaanxi NDV isolates, thereby altering
antigenicity of recent shaanxi NDV strains.
Vaccination is the most important way to prevent
NDV infections [16, 24]. In the present study, the inacti-
vated vaccine prepared from a recent Shaanxi strain
NDV/Chicken/TC/1/2011 protected all the chickens
from morbidity and mortality against its homologous
challenge. However, the group immunized with LaSota
strain inactivated and attenuated LaSota vaccines had
17 % and 25 % mortality rate, respectively. Our results
are argreement with previous reports in using LaSota
vaccine to immunize chicken in China or Taiwan [5, 25].
Furthermore, no obvious clinical signs or mortality was
observed in birds receiving either Oil-NDV/Chicken/
TC/1/2011 or Oil-NDV/Chicken/TC/1/2011 plus atten-
uated LaSota vaccines, and conferred protection from
morbidity and death in all chickens subjected to NDV/
Chicken/TC/1/2011 strain challenge.
Conclusions
In conclusion, this study provides evidences, suggesting
that recent Shaanxi strains are immune response-escaping
antigenic variants that were responsible for these new
NDV outbreaks in northwestern China. Therefore, a ND
inactivated vaccine must be prepared from new local
strains of velogenic NDV.
Materials and methods
Virus isolation and animals
Forty Newcastle diseases suspected lungs; tracheal rings
of the dead chickens (either Hy-Line Brown or Roman
White chickens) from nine different poultry farms were
collected from both Tongchuan city and Yaoxian county
of Shaanxi province in China during 2011. The ages of
these chickens range from 9 to 38–week-old. All samples
were propagated in the allantoic sacs of 10-day-old SPF
chicken embrocated eggs at 37 °C for 3–7 days.
Hemagglutination (HA) tests and hemagglutination-
inhibition (HI) tests were conducted as described previ-
ously [36]. Nine NDV strains were purified by plaque
purification three times. Each virus was coded as follows:
virus name/isolation host/isolation place abbreviation/
case number/year isolated. For example, NDV/Chicken/
TC/1/2011 indicates that the sample is case no. 1 of a
NDV strain isolated from the 2011 outbreak in Tong-
chuan, Shaanxi province. Intracerebral pathogenicity
index (ICPI) test and mean death time (MDT) of
chicken embryos test were performed using the OIE rec-
ommended method. All NDV isolates and reference iso-
lates are shown in Table 1.
Seventy-eight of 5 days old specific pathogen-free
(SPF) White Leghorn chickens were supplied by Green
Square Biological Engineering Company, Yangling, china.
Table 5 Neutralization titres of chicken immunized with different vaccine combinations using NDV/Chicken/TC/1/2011 strain as an
antigen
Serum of chicken
Vaccine groupa 1 2 3 4 5 6 7 8 9 10 11 12
Oil-TC/1 128 256 256 64 256 256 256 256 128 64 128 128
Oil-Las 64 64 32b 64 64 64 64 64 64 64 128 16b
Live-Las 64 64 64 64 64 128 32b 64 16b 32b 64 64
Oil-TC/1 plus Live-Las 64 64 64 128 256 128 128 128 128 256 256 256
Oil-Las plus Live-Las 64 64 128 256 128 128 128 128 32b 64 128 128
aThe neutralization titer was undetectable in both un-inoculated and negative control group chickens
bdeath
Table 6 Antibody response and post-challenge mortality of
chicks immunized with different vaccines and then challenged
with NDV/Chicken/TC/1/2011
NDV vaccine a Mortality in each
challengeb (%) 7DPC c
NDV-HI GMTd against
LaSota strain 56 DPVe
14 DPC
Oil-TC/1 0 147 1024
Oil-Las 17 147 1024









100 All died All died
aAt the age of 3 weeks, twelve chicks per group were vaccinated, respectively.
After 2 weeks, a booster dose of each vaccine was administered to the bird.
Blood samples were taken on 3 week after booster
bOral challenge with the allantonic fluid of virulent
NDV/Chicken/TC/1/2011 isolate
cDPC: days post-challenge
dNDV-HI GMT: geometric mean titer of NDV hemagglutination-inhibition titer
eDPV: days post-vaccination
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All birds were housed in isolators in the laboratory animal
facility under negative pressure with food and water pro-
vided ad libitum. At the age of 3 weeks, the birds were
inoculated with vaccines. All animal experimental proce-
dures were approved by the Ethical and Animal Welfare
Committee of Shannxi Province and were in compliance
with the China law on animal experiments.
Viral RNA extraction for reverse transcription (RT)-
polymerase chain reaction (PCR)
Viral RNA was extracted using TIAN amp Virus DNA/
RNA kit according to manufacturer instructions. To per-
form RT-PCR, the NDV-RNA was extracted directly
from the allantoic fluid of the NDV-inoculated embryos.
After purification, the purified NDV genomic RNA was
used to synthesize cDNA by reverse transcription. The
primers for amplification of the F and HN genes of NDV
were designed on the basis of LaSota sequences (acces-
sion no. JF950510). The primer sequences for amplifica-
tion of F gene were F1 (5′-TGTAGTAACGGG
AGACAAAG CAG-3′; identical to nucleotides 4669 to
4691) and F2 (5′-GAATAAATACCAG AGACATA
GGGA-3′; complementary to nucleotides 5625 to 5601).
The expected size of a PCR-amplified fragment is
957 bp in length. The upstream region of the HN gene
of NDV isolates was amplified by PCR with the primers:
HN1 (5′-AATTTCATCCCAGCGCCTAC-3′, identical
to nucleotides 6893 to 6912) and HN2 (5′-ATCAT-
CAAGCATCGTCCC-3′; complementary to nucleotides
7894 to 7877). Primers HN3 (5′-AGAGTCGTGCTG-
GAGAAT-3′, identical to nucleotides 6431 to 6448) and
HN4 (5′-CTACCTGTCCGAGTGAAA-3′; complemen-
tary to nucleotides 7768 to 7751) were used to amplify
the downstream region of the HN gene. The expected
upstream and downstream regions of the PCR products
are 1002 bp and 1338 bp in length, respectively. These 2
regions overlap and cover the full-length HN gene. The
synthesized cDNA was used as the template for PCR
amplification. PCR reactions of F gene were subjected to
35 cycles consisting of denaturation for 50 s at 94 °C,
annealing for 50 s at 49 °C, and extension for 1 min at
72 °C and one final extension cycle at 72 °C for 10 min.
The annealing temperatures of HN1 and HN2 genes
were 43 °C and 46 °C, respectively, and other procedures
were same as described above. After completing PCR,
10 μL of the reaction mixture was loaded onto a 1.5 %
Table 7 Frequency of detection of challenge virus in different vaccine groups
Group Post-challenge samples (no. positive/total)
Day 2 Day 4 Day6 Day9
Oa Cb O C O C O C
Oil- TC/1 12/12c 10/12 4/12 4/12 2/12 1/12 0 0
Oil-Las 12/12 11/12 10/12 8/12 7/10 6/10 3/10 2/10
Live-Las 12/12 10/12 9/12 8/12 5/10 4/10 2/9 2/9
Oil- TC/1plus
Live-Las
12/12 10/12 3/12* 3/12* 1/12 0 0 0
Oil-Las plus
Live-Las
12/12 11/12 8/12 7/12 5/12 3/12 2/11 1/11
Un-inoculated
control
12/12 12/12 12/12 12/12 NSd NS NS NS
aOropharyngeal swabs. bCloacal swabs. cThe number in front of the slash represents the number of animals, which had detectable viral genome RNA; the number
behind the slash stands for the total number of animals in this group. dNo survivors. *Significant difference (P < 0.05) among immunized groups with the column
Fig. 3 Virus shedding titers from bird oropharyngeal swabs collected
on selected days after NDV/chicken/TC/1/2011 strains challenge. a
Mean virus titers of oropharyngeal swabs of immunized groups on all
sampling days. b Comparison of oropharyngeal virus titers at 2 day
post-challenge. *Significant difference (P < 0.05) from Oil-Las
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agarose gel containing 0.5 μg/mL of ethidium bromide
for electrophoresis and subsequent visualization by UV
transillumation. The PCR products were sent out for se-
quencing after cloning purified.
Amino acid sequence and phylogenetic analyses
The F and HN gene sequences of NDVs were analyzed
and compared by a DNAStar software program. Nucleo-
tide and deduced amino acid sequences of emerging
Shaanxi strains of NDV were compared with the previ-
ously published sequences. Clustalx and Mega 4.0 were
used to construct phylogenetic trees based on the F (1–
389 bp) and the full-length HN gene (1716 bp) se-
quences. All recent Shaanxi strains, vaccine strains, and
reference NDV strains were listed in Table 1. The Clone
30, LaSota, Mukteswar, and B1 strains are attenuated
vaccine strains that widely used in China and in the
world. The Herts/33 is an inactivated vaccine strain.
Hemagglutination inhibition assay
Blood samples were taken on 3 week after the last vaccin-
ation, and sera were isolated and the hemagglutination
inhibition (HI) assay was performed using four haemag-
glutinating units of antigen. Sera of un-inoculated birds
were collected and used as a negative control. All sera
were inactivated at 56°Cfor 30 min and stored at −80 °C
until used. The geometric mean antibody titers were
expressed on a log2 scale. The antigen used in this experi-
ment was LaSota vaccine strain that is used as a standard
antigen in the HI test routinely used in ND diagnostic
laboratories.
Cross virus-neutralization (VN) assay
The serologic relatedness of LaSota and NDV/Chicken/
TC/1/2011 NDV strains as well as between NDV/
Chicken/TC/1/2011 strain and other eight Shannxi
strains were determined using a virus-neutralization
(VN) test. The cross-reactivity was examined and R
value was determined as described previously [37]. R
value is to determine the degree of antigenic similarity
of two viruses, which can be used for the similarity ana-
lysis of the protein antigen in different virus strains. Ten
groups of 30 specific-pathogen-free broilers each were
first vaccinated with either inactivated vaccines (nine
Shannxi NDV strains) or LaSota vaccine, and then
boosted by either Shannxi NDV strains or LaSota vac-
cine. Serum was reacted against each other in a VN test.
Briefly, Two-fold serial dilutions of sera were mixed with
approximately 100 tissue culture infectious doses (TCID)
50 % for 60 min at 37 °C in 96-well microtiter plates.
The TCID50 of nine Shannxi NDV strains and LaSota
vaccine strain were measured by the method of Reed
and Muench on chicken embryo fibroblast (CEF). After
the hyperimmune serum of two viruses were 2-fold seri-
ally diluted, they were mixed with equal volume contain-
ing 100 TCID50 two viruses and then reacted at room
temperature for 1 h. The culture medium was discarded
and virus-serum mixture was added to trace cell reaction
plates containing monolayer cells as 0.1 ml/well. Each
dilution was carried out for 8 repeats. Addition of main-
tenance medium after 37 °C for 2 h, while virus control
containing 100 TCID50, blank cell control and serum
control were included. Calculation of the 50 % serum
neutralization end after culturing 72 h was performed.
All neutralization tests were performed twice and geo-
metric mean titer (GMT) were calculated. The R-value
was calculated as described previously [38]. R values
higher than 0.70 prove antigenic identity, R values be-
tween 0.70 and 0.33 prove antigenic relatedness meaning
minor subtype differences, and R values between 0.32
and 0.11 indicate loose relatedness meaning major sub-
type difference, whereas R values below 0.11 indicate no
relatedness at all meaning serotype difference [37].
Cross-protectivity
Both NDV/Chicken/TC/1/2011 strains and vaccine
strain LaSota were used to prepare monovalent oil-
emulsion vaccines as described previously [5]. Live vac-
cine of the LaSota strain from a commercial source
(Green Square Biological Engineering Company, Yangling,
china) was also used. As shown in Table 8, seventy-eight
SPF White Leghorn chickens were randomly divided into
seven groups. At the age of 3 weeks, the chickens were in-
oculated. Birds received LaSota attenuated vaccine viruses
Table 8 Experimental groups and design for chickens used in this study
Group Number of chicks Vaccine dose Challenged virus strain and dose
Oil-TC/1 12 0.4 ml 106EID50 NDV/TC/1
a
Oil-Las 12 0.4 ml 106EID50 NDV/TC/1
Live-Las 12 1 dose 106EID50 NDV/TC/1
Oil-TC/1 plus Live-Las 12 0.4 ml/1 dose 106EID50 NDV/TC/1
Oil-Las plus Live-Las 12 0.4 ml/1 dose 106EID50 NDV/TC/1
Un-inoculated control 12 PBS 106EID50 NDV/TC/1
Negative control 6 PBS PBS
a NDV/TC/1: NDV/Chicken/TC/1/2011; Oil-TC/1: inactivated oil mulsion-NDV/ Chicken/TC/1/2011; Oil-Las: oil emulsion-LaSota; Live-Las: LaSota attenuated vaccine
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that were inoculated one dose commercial live-LaSota
(Live-Las) via eye-drop and intra-nasal routes. Birds re-
ceived inactivated vaccines that were injected subcutane-
ously with 0.4 ml of inactivated oil emulsion-NDV/
Chicken/TC/1/2011 strains (Oil-TC/1) and oil emulsion-
LaSota (Oil-Las), respectively, while the control group was
injected with phosphate-buffered saline (PBS). After
2 weeks, a booster dose of each vaccine was administered
to the birds.
The cross protectivity of each group vaccine was
assessed in 3 week after booster. All birds were challenged
through eye-drop and intra-nasal routes with 104 ELD50
of NDV strain NDV/Chicken/TC/1/2011. Challenge-free
birds were administrated with PBS via the same route as
the negative control. Following challenge, birds were ob-
served for clinical signs and death during 14 day post-
challenge (pc). Moribund chickens were euthanized with
intravenous sodium pentobarbital at a dose of 100 mg/kg
and counted dead for the next day.
Necropsies were completed on selected birds to assess
the presence of gross pathological lesions. Oropharyn-
geal and cloacal swabs were collected at 0, 2, 4, 6 and
9 days pc for virus isolation and titration as previously
described [39] and virus titers were expressed as log10
EID50/ml. The oropharyngeal positive samples were then
quantified the viral loads as previously reported [4].
Statistical analysis
Statistical analysis of serology titers and virus titers
were performed using IBM statistical package for social
sciences (SPSS) statistical software. A probability (p)
value < 0.05 was considered statistically significant.
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